Tue, May 23, 2017 6:00 PM - 7:00 PM BST
The Federal Circuit and the Supreme Court are poised to issue new guidance on the BPCIA governing the abbreviated pathways for biosimilars. In our upcoming webinar, John Adkisson, Tasha Francis, and Jenny Shmuel will provide an overview of the pending issues and the potential ramifications for the biologic and biosimilar industries.
You will learn about the issues pending before these courts, including:
Updates in the ongoing dispute as to whether the "patent dance" is optional
The contours of the “Notice of Commercial Marketing” requirement.
The scope of discovery in a BPCIA litigation.
The weight accorded to materials exchanged in the “patent dance” in an infringement determination.
If you are interested in keeping up to date with biosimilars issues, this complimentary webinar is for you.